Africa Malaria Treatment Market Size Set Expands at Significant CAGR of 3.54% During 2024–2030 to Reach USD 124.54 Million by 2030

Published | 02 February 2024

Treatment and prevention for malaria are highly sought after due to the disease's high incidence. Africa's population is expanding quickly. There are more people at risk of catching malaria as the population grows.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Africa Malaria Treatment Market size at USD 108.93 Million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Africa Malaria Treatment Market size to expand at a CAGR of 3.54% reaching a value of USD 124.54 Million by 2030. The government's expanded awareness efforts and the quick development of antimalarial medicine development are the main factors driving the market for malaria treatments in Africa. In sub-Saharan Africa in 2022, 59% of children with fevers sought advice or medical help from a facility or practitioner.  There are variations in the behaviour of sick children seeking medical attention based on their residential location; children living in cities are more likely to be admitted than those in rural areas.

Opportunity: Advancement in diagnostic tools

Advanced diagnostic tools, including rapid diagnostic tests (RDTs) and molecular diagnostic techniques, enable early detection of malaria infections. Early diagnosis allows for timely initiation of treatment, reducing the severity of the disease and the risk of complications. Many advanced diagnostic tools are designed for point-of-care testing, allowing healthcare providers to perform rapid and on-site malaria testing. This is particularly beneficial in resource-limited settings where access to centralized laboratories may be limited.

Impact of Geopolitical Tensions on Africa Malaria Treatment Market

Healthcare services can be disrupted by geopolitical tensions, conflicts, and instability. This involves the suspension of regular medical care, disease monitoring, and the provision of necessary medications, such as antimalarial medications. The difficulties in quickly diagnosing and treating malaria can be made worse by disruptions in the provision of healthcare services. Humanitarian crises can be caused by or result from geopolitical conflicts, uprooting populations and putting a burden on the healthcare system already in place. Under such circumstances, it becomes more difficult to provide consistent and effective malaria treatment, which increases the susceptibility of impacted communities.

Sample Request @ https://www.blueweaveconsulting.com/report/africa-malaria-treatment-market/report-sample

Africa Malaria Treatment Market

Segmental Information

Africa Malaria Treatment Market - By Treatment

Based on treatment, due to Africa's high malaria case burden—the majority of which are caused by the Plasmodium falciparum parasite—the prescription drug segment is anticipated to hold a sizable proportion of the market during the projected period. Because malaria is an endemic disease, it is imperative to have access to appropriate prescription medications for the treatment and management of the illness. Malaria cases are being diagnosed and treated at a higher rate in several African countries thanks to initiatives to upgrade the infrastructure and accessibility of healthcare. Prescription drug demand is rising as more people have access to healthcare facilities and as part of a comprehensive malaria treatment plan.

Competitive Landscape

The Africa Malaria Treatment Market is fragmented, with numerous players serving the market. The key players dominating the Africa Malaria Treatment Market include Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Zydus Cadila, Bliss GVS Pharma Ltd. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge in the overall market.

Don’t miss the business opportunity of the Africa Malaria Treatment Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The report's in-depth analysis provides information about growth potential, upcoming trends, and the Africa Malaria Treatment Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Africa Malaria Treatment Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

About Us

BlueWeave Consulting provides all-inclusive Market Intelligence (MI) Solutions to businesses regarding various products and services online & offline. We offer comprehensive market research reports by analyzing qualitative and quantitative data to boost your business solution's performance. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are a promising digital MI solutions company providing agile assistance to make your business endeavors successful.

Contact Us:

BlueWeave Consulting & Research Pvt Ltd

+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662

info@blueweaveconsulting.com